Kalogeropoulos et al., 2009 - Google Patents
Utility of the Seattle Heart Failure Model in patients with advanced heart failureKalogeropoulos et al., 2009
View HTML- Document ID
- 8754418399165110653
- Author
- Kalogeropoulos A
- Georgiopoulou V
- Giamouzis G
- Smith A
- Agha S
- Waheed S
- Laskar S
- Puskas J
- Dunbar S
- Vega D
- Levy W
- Butler J
- Publication year
- Publication venue
- Journal of the American College of Cardiology
External Links
Snippet
Objectives: The aim of this study was to validate the Seattle Heart Failure Model (SHFM) in patients with advanced heart failure (HF). Background: The SHFM was developed primarily from clinical trial databases and extrapolated the benefit of interventions from published …
- 206010007554 Cardiac failure 0 title abstract description 146
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3418—Telemedicine, e.g. remote diagnosis, remote control of instruments or remote monitoring of patient carried devices
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3406—Local monitoring or local control of medical devices, e.g. configuration parameters, graphical user interfaces [GUI] or dedicated hardware interfaces
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kalogeropoulos et al. | Utility of the Seattle Heart Failure Model in patients with advanced heart failure | |
| Kapur et al. | Criteria for defining stages of cardiogenic shock severity | |
| Tromp et al. | Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction | |
| Huffman et al. | Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project | |
| Kiani et al. | The effect and relationship of frailty indices on survival after transcatheter aortic valve replacement | |
| Chatterjee et al. | Modifiable risk factors for incident heart failure in atrial fibrillation | |
| Shah et al. | Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes | |
| Bilchick et al. | Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death | |
| Kalogeropoulos et al. | Progression to stage D heart failure among outpatients with stage C heart failure and reduced ejection fraction | |
| Dondo et al. | β-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction | |
| Shadman et al. | A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model | |
| Pandey et al. | Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation | |
| Ruo et al. | Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study | |
| Fonarow et al. | Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program | |
| Chow et al. | Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy | |
| Khalid et al. | Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study | |
| Zweck et al. | Clinical course of patients in cardiogenic shock stratified by phenotype | |
| Cohen-Solal et al. | Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure | |
| Zamora et al. | Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas | |
| Gupta et al. | Heart failure with preserved ejection fraction in African Americans: the ARIC (Atherosclerosis Risk In Communities) study | |
| Kapelios et al. | Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry | |
| Zheng et al. | Coronary artery bypass graft surgery and percutaneous coronary interventions in patients with unprotected left main coronary artery disease | |
| Ton et al. | Impact of female sex on cardiogenic shock outcomes: a cardiogenic shock working group report | |
| Kanwar et al. | Pulmonary artery catheter use and risk of in-hospital death in heart failure cardiogenic shock | |
| Pun et al. | Serum potassium levels and risk of sudden cardiac death among patients with chronic kidney disease and significant coronary artery disease |